Some women will get Zometa (zoledronic acid) to prevent recurrent breast cancer

July 2008

Some women will get Zometa (zoledronic acid) to prevent recurrent breast cancer.

This bisphosphonate is already used for bone mets from breast cancer...to reduce bone pain and fractures.

Now evidence suggests that giving Zometa earlier helps PREVENT the bone mets and breast cancer recurrence.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote